Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells
Glucose deprivation and hypoxia frequently occur in solid tumor cells, including pancreatic cancer cells. Glucose deprivation activates the unfolded protein response (UPR) and causes the upregulation of glucose-regulated protein 78 (GRP78). Induction of GRP78 has been shown to protect cancer cells. Therefore, shutting down of GRP78 expression may be a novel strategy in anticancer drug development. Based on this understanding, a screening system established for anticancer agents that exhibit selective cytotoxicity on pancreatic cancer cells under glucose-deprived conditions. To test this hypothesis, the new compounds isolated, pancastatin A (PST-A) and B (PSTB), from Ponciri Fructus. PST-A and B were identified as glabretal triterpenoid moieties by electrospray ionization mass spectrometry and nuclear magnetic resonance spectroscopic methods. PST-A and B suppressed the accumulation of the UPR hallmark gene, GRP78, during glucose deprivation. Furthermore, PST-A and B showed selective cytotoxicity on PANC-1 pancreatic cancer cells under glucose deprivation. Interestingly, PST-A and B had no effect on these cells under normal growth conditions. Our results suggest that PST-A and B act as novel therapeutic agents to induce selective cell death in glucose-deprived pancreatic cancer cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Journal of microbiology and biotechnology - 30(2020), 5 vom: 28. Mai, Seite 733-738 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Park, Hae-Ryong [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.01.2021 Date Revised 29.02.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.4014/jmb.2002.02002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310633087 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM310633087 | ||
003 | DE-627 | ||
005 | 20240229233405.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4014/jmb.2002.02002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1311.xml |
035 | |a (DE-627)NLM310633087 | ||
035 | |a (NLM)32482939 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Park, Hae-Ryong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.01.2021 | ||
500 | |a Date Revised 29.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Glucose deprivation and hypoxia frequently occur in solid tumor cells, including pancreatic cancer cells. Glucose deprivation activates the unfolded protein response (UPR) and causes the upregulation of glucose-regulated protein 78 (GRP78). Induction of GRP78 has been shown to protect cancer cells. Therefore, shutting down of GRP78 expression may be a novel strategy in anticancer drug development. Based on this understanding, a screening system established for anticancer agents that exhibit selective cytotoxicity on pancreatic cancer cells under glucose-deprived conditions. To test this hypothesis, the new compounds isolated, pancastatin A (PST-A) and B (PSTB), from Ponciri Fructus. PST-A and B were identified as glabretal triterpenoid moieties by electrospray ionization mass spectrometry and nuclear magnetic resonance spectroscopic methods. PST-A and B suppressed the accumulation of the UPR hallmark gene, GRP78, during glucose deprivation. Furthermore, PST-A and B showed selective cytotoxicity on PANC-1 pancreatic cancer cells under glucose deprivation. Interestingly, PST-A and B had no effect on these cells under normal growth conditions. Our results suggest that PST-A and B act as novel therapeutic agents to induce selective cell death in glucose-deprived pancreatic cancer cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a GRP78 | |
650 | 4 | |a Pancastatin A | |
650 | 4 | |a glucose deprivation | |
650 | 4 | |a pancastatin B | |
650 | 4 | |a pancreatic cancer | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Endoplasmic Reticulum Chaperone BiP |2 NLM | |
650 | 7 | |a HSPA5 protein, human |2 NLM | |
650 | 7 | |a Heat-Shock Proteins |2 NLM | |
650 | 7 | |a Triterpenes |2 NLM | |
650 | 7 | |a pancastatin A |2 NLM | |
650 | 7 | |a pancastatin B |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of microbiology and biotechnology |d 1997 |g 30(2020), 5 vom: 28. Mai, Seite 733-738 |w (DE-627)NLM093752350 |x 1738-8872 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2020 |g number:5 |g day:28 |g month:05 |g pages:733-738 |
856 | 4 | 0 | |u http://dx.doi.org/10.4014/jmb.2002.02002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2020 |e 5 |b 28 |c 05 |h 733-738 |